Clinical trial
Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II)
NCT07343076 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II)
- Lead sponsor
- RenJi Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 28, 2026
- Completion date
- February 28, 2031
- Enrollment
- 1,904 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
non-st-elevation acute coronary syndrome, nste-acs (nstemi and ua), nstemi, nstemi - non-st segment elevation mi